Rolapitant specifically targets and inhibits the NK1 receptors in the brain. By blocking these receptors, the medication helps to prevent the emetic (vomiting) reflex that is often triggered by chemotherapy agents. This makes it particularly effective in managing delayed nausea and vomiting, which can occur 24 hours to several days after chemotherapy.
